Physician profile
Charles C Thomas
NPI 1447200738
$693.23
in general payments reported to CMS, 2019-2025
22 companies · $76.23 in 2025
The $76.23 reported for 2025 was less than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $526 · 2020: $91.40 · 2025: $76.23.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $76.23.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $76.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $102.62 | 2019 | |
| Novo Nordisk INC | $76.23 | 2025 | Wegovy, Ozempic |
| Astellas Pharma US INC | $69.30 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $64.79 | 2019-2020 | |
| Celgene Corporation | $55.49 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $50.98 | 2019 | |
| Exelixis INC. | $42.31 | 2019 | |
| Janssen Biotech, INC. | $26.71 | 2019 | |
| Eisai INC. | $22.56 | 2019 | |
| Karyopharm Therapeutics INC. | $20.28 | 2020 | |
| Genzyme Corporation | $18.76 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $16.30 | 2019 | |
| Incyte Corporation | $13.77 | 2020 | |
| Novocure INC. | $13.75 | 2019 | |
| Alexion Pharmaceuticals, INC. | $13.31 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Taiho Oncology, INC. | $13.16 | 2019 | |
| Lilly USA, LLC | $13.11 | 2019 | |
| Merck Sharp & Dohme LLC | $12.75 | 2019 | |
| Seagen INC. | $12.71 | 2019 | |
| Puma Biotechnology, INC. | $11.94 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $11.32 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $11.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.